MedPath

Photodynamic diagnosis of non muscle invasive bladder cancer using fluorescence cystoscopy with oral administration of 5-aminolevulinic acid(5-ALA)

Phase 3
Recruiting
Conditions
on muscle invasive bladder cancer
Registration Number
JPRN-UMIN000010798
Lead Sponsor
Department of urology and Andrology, Kansai Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

patient who has potential complication of local disorder and systematic absorption of 5-ALA such as solar photosensitivity and liver dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety:The occurrence frequency and degree of adverse event were investigated through the procedures.
Secondary Outcome Measures
NameTimeMethod
Diagnostic accuracy : The levels in images of the 5-ALA-induced fluorescence were compared with the pathological results. The diagnostic capability of photodynamic diagnosis (PDD) using fluorescence (blue light) endoscopy was compared to that in conventional diagnostic method using white light endoscopy.
© Copyright 2025. All Rights Reserved by MedPath